共 110 条
[1]
Almstedt M(2010)The DNA demethylating agent 5-aza-2 ‘-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells Leuk Res 34 899-905
[2]
Blagitko-Dorfs N(2011)MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing Cancer Immunol Immunother 60 1299-1307
[3]
Duque-Afonso J(2007)Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines Leuk Res 31 497-506
[4]
Karbach J(2014)Exosomes from myeloid-derived suppressor cells carry biologically active proteins J Proteome Res 13 836-843
[5]
Pfeifer D(2014)Low-dose 5-aza-2′-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells Mol Med 20 248-256
[6]
Jaeger E(2010)In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia Blood 116 129-139
[7]
Luebbert M(2010)Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine. Cancer Immunol Immunother 59 697-706
[8]
Bao L(2016)Improving cancer immunotherapy by targeting the STATe of MDSCs Oncoimmunology 5 e1196312-3356
[9]
Dunham K(2005)DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling Development 132 3345-5747
[10]
Lucas K(2014)The role of myeloid-derived suppressor cells in immune ontogeny Front Immunol 5 387-1131